| Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines M Oladejo, W Paulishak, L Wood Seminars in Cancer Biology, 2022 | 18 | 2022 |
| Listeria-based immunotherapy directed against CD105 exerts anti-angiogenic and anti-tumor efficacy in renal cell carcinoma M Oladejo, HM Nguyen, A Silwal, B Reese, W Paulishak, MM Markiewski, ... Frontiers in immunology 13, 2022 | 9 | 2022 |
| A Listeria-based vaccine targeting ISG15 exerts anti-tumor efficacy in renal cell carcinoma HM Nguyen, M Oladejo, W Paulishak, LM Wood Cancer Immunology, Immunotherapy, 1-15, 2022 | 8 | 2022 |
| Targeting Ubiquitin-like Protein, ISG15, as a Novel Tumor Associated Antigen in Colorectal Cancer HM Nguyen, S Gaikwad, M Oladejo, W Paulishak, LM Wood Cancers 15 (4), 1237, 2023 | 5 | 2023 |
| Dynamic tumor microenvironment, molecular heterogeneity, and distinct immunologic portrait of triple-negative breast cancer: an impact on classification and treatment approaches HM Nguyen, W Paulishak, M Oladejo, L Wood Breast Cancer, 1-20, 2022 | 5 | 2022 |
| Expanding Bacteria Cell Therapy Through Application of Bacteria as Drug Delivery Vehicles W Paulishak Indiana University, 2020 | | 2020 |
| Progress Towards Design of a Light Activated COX‐2 Inhibitor W Paulishak, C Armstrong, M DeBerardino, C Rous, P Mertz, C Streu The FASEB Journal 30, 612.9-612.9, 2016 | | 2016 |
